AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness
AstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook